Place of Origin : Beijing,China
Post Date : 22-06-2021
Expiry Date : 31-12-2021

Founded In 1992, Beijing Beilu Pharmaceuticals Company Limited Is Mainly Engaged In The Research & Development, Production And Sales Of Pharmaceutical Products. It Is High-tech Innovation Company With Core Competence In The Contrast Medium Domestic. It Has Around 650 Employees With 0.82 Bn/? Revenue In 2019. Beilu Provides Complete Contrast Media Products Suitable For X-Ray And Magnetic Resonance Imaging (MRI), And It Is The Leading Manufacturer In The Contrast Media Field In China. It Is One Of The 1st Batches Of Listed Enterprises In GEM Of SZSE (Ticker: 300016.SZ) In China.

Iodixanol Injection Is A Contrast Media That Is Isotonic With Plasma. It Has Excellent Cardiac Safety And Renal Safety, Which Is Most Comfortable To Use, Especially Suitable For High Risk Patients.

Product Name: Iodixanol Injection
Generic Name: Iodixanol Injection
Type: Injectable Contrast Media For CT/X-ray
Ingredients: Iodixanol
Specification:
(1) 50ml: 16 GI
(2) 100 Ml: 32 GI
(3) 100 Ml: 27 GI
Administration: For Intravascular Use Only
Adverse Reactions: See The Details From The Package Insert
Shelf Life: 24 Months
Ndications Of Iodixanol Injection
The Visipaque Contrast Media / Iodixanol Visipaque / Visipaque Contrast Is Mainly Used For Adult Angiocardiography, Cerebral Angiography, Peripheral Arteriography, Abdominal Angiography, Urography, Venography And Enhanced CT Scan, Children Angiocardiography, Urography And Enhanced CT Scan. And This Visipaque Have Specifications Of Visipaque 320.
For More Precautions, Please Refer To The Package Insert.